Artelo Biosciences ARTL
NASDAQ ARTL
$2.57 -0.05 (-1.91%)
As of: Oct 21, 2026 · 3:59 PM EDT

Artelo Biosciences (ARTL) Capital Expenditures (2017 - 2018)

Updated

Artelo Biosciences (ARTL) posted Capital Expenditures of -$188,000 for FY2025.

Analysis

Artelo Biosciences (ARTL) Capital Expenditures (2017 - 2018) Analysis & Trends

  • The FY2025 figure stands as the highest annual Capital Expenditures since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Artelo Biosciences 52,106.49 -5.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2018 -42.00
Feb 28, 2018 20.00
Nov 30, 2017 867.00
API Access

Artelo Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARTL&period=max&api_key=YOUR_API_KEY